SYK-3BP2 Pathway Activity in Parenchymal and Myeloid Cells Is a Key Pathogenic Factor in Metabolic Steatohepatitis
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
SYK-3BP2 Pathway Activity in Parenchymal and Myeloid Cells Is a Key Pathogenic Factor in Metabolic Steatohepatitis
Authors
Keywords
SYK, 3BP2, TREM1, TLR4, MAFLD, NASH, Fibrosis
Journal
Cellular and Molecular Gastroenterology and Hepatology
Volume -, Issue -, Pages -
Publisher
Elsevier BV
Online
2021-08-16
DOI
10.1016/j.jcmgh.2021.08.004
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Gain-of-function variants in SYK cause immune dysregulation and systemic inflammation in humans and mice
- (2021) Lin Wang et al. NATURE GENETICS
- MAFLD: A consensus-driven proposed nomenclature for metabolic associated fatty liver disease
- (2020) Mohammed Eslam et al. GASTROENTEROLOGY
- Hepatic FNDC5 is a potential local protective factor against Non-Alcoholic Fatty Liver
- (2020) Clémence M. Canivet et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Lytic cell death in metabolic liver disease
- (2020) Jérémie Gautheron et al. JOURNAL OF HEPATOLOGY
- Chronic Inflammation in Non-Alcoholic Steatohepatitis: Molecular Mechanisms and Therapeutic Strategies
- (2020) Carmelo Luci et al. Frontiers in Endocrinology
- Function of TREM1 and TREM2 in Liver-Related Diseases
- (2020) Huifang Sun et al. Cells
- The Role of Innate Immune Cells in Nonalcoholic Steatohepatitis
- (2019) Jingjing Cai et al. HEPATOLOGY
- Targeting SYK signaling in myeloid cells protects against liver fibrosis and hepatocarcinogenesis
- (2019) Alejandro Torres-Hernandez et al. ONCOGENE
- The Differential Expression of Cide Family Members is Associated with Nafld Progression from Steatosis to Steatohepatitis
- (2019) Arnaud Sans et al. Scientific Reports
- Apolipoprotein C3 induces inflammation and organ damage by alternative inflammasome activation
- (2019) Stephen Zewinger et al. NATURE IMMUNOLOGY
- CC chemokine receptor 2 promotes recruitment of myeloid cells associated with insulin resistance in nonalcoholic fatty liver disease
- (2018) Richard Parker et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Nonalcoholic Fatty Liver Disease as a Nexus of Metabolic and Hepatic Diseases
- (2018) Varman T. Samuel et al. Cell Metabolism
- Non-alcoholic steatohepatitis pathogenesis: sublethal hepatocyte injury as a driver of liver inflammation
- (2018) Samar H Ibrahim et al. GUT
- Tyrosine kinase SYK is a potential therapeutic target for liver fibrosis
- (2018) Chen Qu et al. HEPATOLOGY
- Therapeutic inhibition of inflammatory monocyte recruitment reduces steatohepatitis and liver fibrosis
- (2018) Oliver Krenkel et al. HEPATOLOGY
- Second-Generation SYK Inhibitor Entospletinib Ameliorates Fully Established Inflammation and Bone Destruction in the Cherubism Mouse Model
- (2018) Tetsuya Yoshimoto et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Therapeutic inhibition of spleen tyrosine kinase in inflammatory macrophages using PLGA nanoparticles for the treatment of non-alcoholic steatohepatitis
- (2018) Dhadhang Wahyu Kurniawan et al. JOURNAL OF CONTROLLED RELEASE
- The innate immune receptor TREM-1 promotes liver injury and fibrosis
- (2018) Anh Thu Nguyen-Lefebvre et al. JOURNAL OF CLINICAL INVESTIGATION
- The role of macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
- (2018) Konstantin Kazankov et al. Nature Reviews Gastroenterology & Hepatology
- Over expression of proteins that alter the intracellular signaling pathways in the cytoplasm of the liver cells forming Mallory-Denk bodies
- (2017) N. Afifiyan et al. EXPERIMENTAL AND MOLECULAR PATHOLOGY
- CD44 is a key player in non-alcoholic steatohepatitis
- (2017) Stéphanie Patouraux et al. JOURNAL OF HEPATOLOGY
- Tmbim1 is a multivesicular body regulator that protects against non-alcoholic fatty liver disease in mice and monkeys by targeting the lysosomal degradation of Tlr4
- (2017) Guang-Nian Zhao et al. NATURE MEDICINE
- Therapeutic Benefits of Spleen Tyrosine Kinase Inhibitor Administration on Binge Drinking-Induced Alcoholic Liver Injury, Steatosis, and Inflammation in Mice
- (2016) Terence N. Bukong et al. ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH
- Non-alcoholic fatty liver disease and risk of type 2 diabetes
- (2016) S. Lallukka et al. BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM
- Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes
- (2016) Zobair M. Younossi et al. HEPATOLOGY
- A role for spleen tyrosine kinase in renal fibrosis in the mouse obstructed kidney
- (2016) Frank Y. Ma et al. LIFE SCIENCES
- Molecular Mechanisms in Genetically Defined Autoinflammatory Diseases: Disorders of Amplified Danger Signaling
- (2015) Adriana Almeida de Jesus et al. Annual Review of Immunology
- Cherubism allele heterozygosity amplifies microbe-induced inflammatory responses in murine macrophages
- (2015) Virginie Prod’Homme et al. JOURNAL OF CLINICAL INVESTIGATION
- Une mutation hétérozygote deSH3BP2amplifie la réponse inflammatoire à l’infection des macrophages dans un modèle de chérubisme chez la souris
- (2015) Marcel Deckert et al. M S-MEDECINE SCIENCES
- Enhanced TLR-MYD88 Signaling Stimulates Autoinflammation in SH3BP2 Cherubism Mice and Defines the Etiology of Cherubism
- (2014) Teruhito Yoshitaka et al. Cell Reports
- Chronic plus binge ethanol feeding synergistically induces neutrophil infiltration and liver injury in mice: A critical role for E-selectin
- (2013) Adeline Bertola et al. HEPATOLOGY
- Non-alcoholic steatohepatitis in morbidly obese patients
- (2013) Albert Tran et al. Clinics and Research in Hepatology and Gastroenterology
- The SYK side of TLR4: signalling mechanisms in response to LPS and minimally oxidized LDL
- (2012) Yury I Miller et al. BRITISH JOURNAL OF PHARMACOLOGY
- The role of SH3BP2 in the pathophysiology of cherubism
- (2012) Ernst J Reichenberger et al. Orphanet Journal of Rare Diseases
- Loss of Tankyrase-Mediated Destruction of 3BP2 Is the Underlying Pathogenic Mechanism of Cherubism
- (2011) Noam Levaot et al. CELL
- Pharmacological inhibition of the chemokine CCL2 (MCP-1) diminishes liver macrophage infiltration and steatohepatitis in chronic hepatic injury
- (2011) Christer Baeck et al. GUT
- Nuclear factor high-mobility group box1 mediating the activation of toll-like receptor 4 signaling in hepatocytes in the early stage of nonalcoholic fatty liver disease in mice
- (2011) Liang Li et al. HEPATOLOGY
- 3BP2-deficient mice are osteoporotic with impaired osteoblast and osteoclast functions
- (2011) Noam Levaot et al. JOURNAL OF CLINICAL INVESTIGATION
- The global obesity pandemic: shaped by global drivers and local environments
- (2011) Boyd A Swinburn et al. LANCET
- 3BP2 Adapter Protein Is Required for Receptor Activator of NFκB Ligand (RANKL)-induced Osteoclast Differentiation of RAW264.7 Cells
- (2010) Amel GuezGuez et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Risk of Cardiovascular Disease in Patients with Nonalcoholic Fatty Liver Disease
- (2010) Giovanni Targher et al. NEW ENGLAND JOURNAL OF MEDICINE
- An Oral Spleen Tyrosine Kinase (Syk) Inhibitor for Rheumatoid Arthritis
- (2010) Michael E. Weinblatt et al. NEW ENGLAND JOURNAL OF MEDICINE
- Hepatic Expression Patterns of Inflammatory and Immune Response Genes Associated with Obesity and NASH in Morbidly Obese Patients
- (2010) Adeline Bertola et al. PLoS One
- Hepatic recruitment of the inflammatory Gr1+monocyte subset upon liver injury promotes hepatic fibrosis
- (2009) Karlin Raja Karlmark et al. HEPATOLOGY
- CCR2 promotes hepatic fibrosis in mice
- (2009) Ekihiro Seki et al. HEPATOLOGY
- Syk kinase is required for collaborative cytokine production induced through Dectin-1 and Toll-like receptors
- (2008) Kevin M. Dennehy et al. EUROPEAN JOURNAL OF IMMUNOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started